These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Freehand MRI-guided preoperative needle localization of breast lesions after MRI-guided vacuum-assisted core needle biopsy without marker placement. van de Ven SM, Lin MC, Daniel BL, Sareen P, Lipson JA, Pal S, Dirbas FM, Ikeda DM. J Magn Reson Imaging; 2010 Jul; 32(1):101-9. PubMed ID: 20575077 [Abstract] [Full Text] [Related]
24. Tumor reduction rate predicts early recurrence in patients with breast cancer failing to achieve complete response to primary chemotherapy. Nagashima T, Sakakibara M, Sangai T, Kazama T, Nakatani Y, Miyazaki M. Breast Cancer; 2010 Apr; 17(2):125-30. PubMed ID: 19459030 [Abstract] [Full Text] [Related]
25. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy. Yang H, Liu H, Peng W, Hua Y. J Comput Assist Tomogr; 2012 Apr; 36(2):196-9. PubMed ID: 22446359 [Abstract] [Full Text] [Related]
26. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging. Nishiura M, Yasuhiro T, Murase K. Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496 [Abstract] [Full Text] [Related]
27. [MRI evaluation of primary chemotherapy response in breast cancer]. Vénat-Bouvet L, Desfougères M, Aubard Y, Mollard J, Fermeaux V, Genet D, Labourey JL, Martin J, Lebrun-Ly V, Maubon A, Tubiana-Mathieu N. Bull Cancer; 2004 Sep; 91(9):721-8. PubMed ID: 15544998 [Abstract] [Full Text] [Related]
29. Factors affecting successful breast conservation for ductal carcinoma in situ. Dillon MF, Mc Dermott EW, O'Doherty A, Quinn CM, Hill AD, O'Higgins N. Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388 [Abstract] [Full Text] [Related]
30. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings. Woodhams R, Kakita S, Hata H, Iwabuchi K, Kuranami M, Gautam S, Hatabu H, Kan S, Mountford C. Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508 [Abstract] [Full Text] [Related]
31. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF, Fraker DL, Czerniecki BJ. Cancer; 2003 Aug 01; 98(3):468-73. PubMed ID: 12879462 [Abstract] [Full Text] [Related]
32. Discordance between pathologic and radiologic tumor size on breast MRI may contribute to increased re-excision rates. Vanderwalde LH, Dang CM, Bresee C, Phillips EH. Am Surg; 2011 Oct 01; 77(10):1361-3. PubMed ID: 22127089 [Abstract] [Full Text] [Related]
33. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Schelfout K, Van Goethem M, Kersschot E, Colpaert C, Schelfhout AM, Leyman P, Verslegers I, Biltjes I, Van Den Haute J, Gillardin JP, Tjalma W, Van Der Auwera JC, Buytaert P, De Schepper A. Eur J Surg Oncol; 2004 Jun 01; 30(5):501-7. PubMed ID: 15135477 [Abstract] [Full Text] [Related]
34. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer. Park AY, Gweon HM, Son EJ, Yoo M, Kim JA, Youk JH. Eur J Radiol; 2014 Apr 01; 83(4):654-9. PubMed ID: 24534119 [Abstract] [Full Text] [Related]
35. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB. Ann Surg Oncol; 2008 Sep 01; 15(9):2542-9. PubMed ID: 18618180 [Abstract] [Full Text] [Related]
37. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, McNeese M, Pierce LJ, Landmann C, Olivotto IA, Borger J, de La Rochefordiere A, Schultz DJ. Cancer; 2001 Mar 15; 91(6):1090-7. PubMed ID: 11267953 [Abstract] [Full Text] [Related]